放射性药物在胰腺癌治疗与诊断中的进展。
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.
作者信息
Xu Yu-Ping, Yang Min
机构信息
Yu-Ping Xu, Min Yang, Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, Jiangsu Province, China.
出版信息
World J Gastrointest Oncol. 2016 Feb 15;8(2):165-72. doi: 10.4251/wjgo.v8.i2.165.
Abstract
Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.
摘要
胰腺癌（PC）是一个重大的健康问题。传统成像方式在可靠评估肿瘤方面准确性有限。最近的研究表明，带有示踪剂的分子成像技术能提供更多生物学相关信息，有利于癌症的诊断。此外，放射性药物在该疾病的治疗中也发挥着更重要的作用。这篇综述总结了放射性标记化合物在胰腺癌诊疗中的进展。
相似文献
1
Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.放射性药物在胰腺癌治疗与诊断中的进展。
World J Gastrointest Oncol. 2016 Feb 15;8(2):165-72. doi: 10.4251/wjgo.v8.i2.165.
2
Prospects in radionuclide imaging of prostate cancer.前列腺癌放射性核素成像的展望。
Prostate. 2012 Aug 1;72(11):1262-72. doi: 10.1002/pros.22462. Epub 2011 Nov 29.
3
Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.用于神经内分泌分化型前列腺癌诊断与治疗的放射性药物
Curr Radiopharm. 2017;10(1):6-15. doi: 10.2174/1874471009666161229123126.
4
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.（18）F/（11）C-胆碱的新临床适应证、正电子发射断层扫描的新型示踪剂和用于前列腺癌分期的有前途的混合设备：文献系统评价。
Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2.
5
Radiolabeled prostate-specific membrane antigen small-molecule inhibitors.放射性标记的前列腺特异性膜抗原小分子抑制剂
Q J Nucl Med Mol Imaging. 2017 Jun;61(2):168-180. doi: 10.23736/S1824-4785.17.02977-6. Epub 2017 Feb 17.
6
Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.横断面成像及正电子发射断层扫描在胰腺癌评估中的作用
Semin Oncol. 2015 Feb;42(1):40-58. doi: 10.1053/j.seminoncol.2014.12.005. Epub 2014 Dec 8.
7
Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.使用18F-氟脱氧葡萄糖的正电子发射断层扫描对胰腺肿块进行术前评估：诊断局限性
World J Surg. 2000 Sep;24(9):1121-9. doi: 10.1007/s002680010182.
8
Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?联合18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在胰腺病变的诊断、分期及再分期方面是否优于单独的正电子发射断层扫描或计算机断层扫描？
Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.
9
A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.前瞻性诊断准确性研究 18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描、多排计算机断层扫描和磁共振成像在胰腺癌的初步诊断和分期中的应用。
Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.
10
[Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].[氟脱氧葡萄糖正电子发射断层扫描（FDG-PET）在胰腺病变鉴别诊断中的应用]
Chirurg. 2001 Sep;72(9):989-94. doi: 10.1007/pl00002602.
引用本文的文献
1
Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers.临床研究确定的乳腺癌和胰腺癌炎症生物标志物。
Front Endocrinol (Lausanne). 2023 Apr 27;14:1106520. doi: 10.3389/fendo.2023.1106520. eCollection 2023.
2
Preliminary study on SPECT/CT imaging of pancreatic cancer xenografts by targeting integrin α5 in pancreatic stellate cells.通过靶向胰腺星状细胞中的整合素α5对胰腺癌异种移植瘤进行SPECT/CT成像的初步研究。
J Cancer. 2021 Jan 18;12(6):1729-1733. doi: 10.7150/jca.51190. eCollection 2021.
3
Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity and through targeting the NF-κB signaling pathway in pancreatic cancer.脱氧土大黄素通过氧化应激诱导细胞凋亡，并通过靶向 NF-κB 信号通路增强吉西他滨在胰腺癌中的敏感性。
Aging (Albany NY). 2020 Jun 11;12(11):11116-11138. doi: 10.18632/aging.103327.
4
Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway.整合素β 4（ITGB4）及其酪氨酸-1510 磷酸化促进胰腺肿瘤发生，并调节 MEK1-ERK1/2 信号通路。
Bosn J Basic Med Sci. 2020 Feb 5;20(1):106-116. doi: 10.17305/bjbms.2019.4255.
5
A Review of Pancreatic Cancer: Epidemiology, Genetics, Screening, and Management.胰腺癌综述：流行病学、遗传学、筛查与管理
Open Access Maced J Med Sci. 2019 Feb 14;7(4):663-671. doi: 10.3889/oamjms.2019.104. eCollection 2019 Feb 28.
6
Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.肿瘤来源的外泌体作为胰腺癌的标志物——液体活检作为肿瘤进展的指标
Oncotarget. 2017 Mar 7;8(10):17279-17291. doi: 10.18632/oncotarget.13973.
本文引用的文献
1
F-18 fluorodeoxyglucose positron emission tomography for differential diagnosis of pancreatic tumors.F-18氟脱氧葡萄糖正电子发射断层扫描在胰腺肿瘤鉴别诊断中的应用
Springerplus. 2015 Mar 31;4:154. doi: 10.1186/s40064-015-0938-2. eCollection 2015.
2
Recent developments in imaging of pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤成像的最新进展。
Ann Gastroenterol. 2015 Apr-Jun;28(2):193-202.
3
Molecular imaging in the era of personalized medicine.个性化医疗时代的分子成像
J Pathol Transl Med. 2015 Jan;49(1):5-12. doi: 10.4132/jptm.2014.10.24. Epub 2015 Jan 15.
4
Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PET.[18F]AlF-NOTA-MAL-Cys39-艾塞那肽-4在胰岛素瘤中的PET初步评估。
J Drug Target. 2015;23(9):813-20. doi: 10.3109/1061186X.2015.1020808. Epub 2015 Mar 11.
5
Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies.晚期胰腺腺癌：当前治疗策略和新兴疗法的综述。
Ther Adv Med Oncol. 2015 Mar;7(2):68-84. doi: 10.1177/1758834014564775.
6
New challenges in perioperative management of pancreatic cancer.胰腺癌围手术期管理中的新挑战。
World J Gastroenterol. 2015 Feb 28;21(8):2281-93. doi: 10.3748/wjg.v21.i8.2281.
7
8
3'-Deoxy-3'-¹⁸F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer.3'-脱氧-3'-¹⁸F-氟代胸苷正电子发射断层扫描作为晚期和转移性胰腺癌患者疾病进展的早期预测指标
Eur J Nucl Med Mol Imaging. 2015 May;42(6):831-40. doi: 10.1007/s00259-015-3000-2. Epub 2015 Feb 12.
9
68Ga-NOTA-exendin-4 PET/CT in detection of occult insulinoma and evaluation of physiological uptake.68Ga-NOTA-艾塞那肽-4 PET/CT在隐匿性胰岛素瘤检测及生理性摄取评估中的应用
Eur J Nucl Med Mol Imaging. 2015 Mar;42(3):531-2. doi: 10.1007/s00259-014-2946-9. Epub 2014 Nov 15.
10
Positron Emission Tomography (PET) in Oncology.正电子发射断层扫描（PET）在肿瘤学中的应用。
Cancers (Basel). 2014 Sep 29;6(4):1821-89. doi: 10.3390/cancers6041821.
Zotero 插件